28 questions · 10 sources
Indication2 questions · 3 sources
Clinical trials13 questions · 5 sources
- Who was studied in the Ibrance PALOMA-2 trial?
- How long does Ibrance plus letrozole delay progression vs letrozole alone (PALOMA-2)?
- Does Ibrance plus letrozole help patients live longer (PALOMA-2 overall survival)?
- What was the response rate with Ibrance plus letrozole (PALOMA-2)?
- Were Ibrance plus letrozole results consistent across subgroups (PALOMA-2)?
- What are the long-term side effects of Ibrance plus letrozole (PALOMA-2)?
- Who was studied in the Ibrance PALOMA-3 trial?
- How long does Ibrance plus fulvestrant delay progression vs fulvestrant alone (PALOMA-3)?
- Does Ibrance plus fulvestrant help patients live longer (PALOMA-3 overall survival)?
- What was the response rate with Ibrance plus fulvestrant (PALOMA-3)?
- Were Ibrance plus fulvestrant results consistent across subgroups (PALOMA-3)?
- What are the long-term side effects of Ibrance plus fulvestrant (PALOMA-3)?
- How long did patients take Ibrance in PALOMA-2 and PALOMA-3?
Safety9 questions · 3 sources
- What are the most common side effects of Ibrance with letrozole (PALOMA-2)?
- What are the most common side effects of Ibrance with fulvestrant (PALOMA-3)?
- What blood test abnormalities occur with Ibrance (PALOMA-2 and PALOMA-3)?
- Does Ibrance cause nosebleeds, dry eye, or blurred vision?
- How common is neutropenia (low neutrophil count) with Ibrance?
- How often did neutropenia lead to Ibrance dose changes (PALOMA-2, PALOMA-3)?
- Was G-CSF allowed for neutropenia in the Ibrance PALOMA-2 and PALOMA-3 trials?
- Can Ibrance cause lung problems (ILD or pneumonitis)?
- How often did side effects lead to stopping Ibrance (PALOMA-2, PALOMA-3)?